[Indoleamine 2,3-dioxygenase 1 modulates the immuneresponse; the new therapeutic targets of this drug].
yamamoto.yasuko.5x@hsmed.kyoto-u.ac.jp
Yasuko
Y
Yamamoto
Yuki
Y
Murakami
Masato
M
Hoshi
Kuniaki
K
Saito
D015195:Drug Design; D006801:Humans; D007109:Immunity / Q000502:physiology*; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase / Q000037:antagonists & inhibitors / Q000502:physiology*; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000276:immunology / Q000378:metabolism
C576710:IDO1 protein, human; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase